General Hospital of Athens "Alexandra"
- Address
- 80 Vasilissis Sofias Avenue, 11528 Athens, Greece
General Hospital of Athens Alexandra - Amyloidosis Research Center
General Hospital of Athens Alexandra is a distinguished medical institution actively engaged in advanced clinical research for rare and complex systemic diseases. The center demonstrates particular expertise in the investigation of novel therapeutic approaches for challenging hematologic and protein misfolding disorders, with a strong focus on improving outcomes for patients with advanced disease stages.
- Light chain (AL) amyloidosis treatment research and clinical trials
- Advanced stage rare disease management and innovative therapeutic interventions
- Monoclonal antibody-based therapies combined with standard of care protocols
The research facility is currently contributing to international multicenter trials evaluating birtamimab, a promising investigational agent for Mayo Stage IV AL amyloidosis patients. This involvement highlights the center's commitment to addressing urgent unmet medical needs in patients with advanced cardiac involvement and high mortality risk, while advancing the scientific understanding of amyloid-targeting immunotherapies and their long-term safety profiles.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 173 other sites in Greece
Therapeutic Area Benchmark — Greece
Select a therapeutic area to compare against other sites in Greece.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Greece
Market Share
Country: Greece
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in General Hospital of Athens "Alexandra"
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Birtamimab with Standard Care versus Placebo in Mayo Stage IV Light Chain Amyloidosis: A Phase 3 Randomized, Double-Blind Study | Prothena Biosciences Limited | Phase III | Not Recruiting | Oct 2021 | May 2025 |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Birtamimab | 1 | Unknown | 2021-10-13 | 2021-10-13 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.